News on Mendelian diseases, hereditary cancer, variant classification, cystic fibrosis testing and more.
The firm has collaborated with Novartis to help pilot the new sickle cell disease test and a treatment in Ghana.
As adoption of personalized medicines has accelerated over the last four years, so has the number of marketed genetic and exome tests.
Genosity will combine its Integrated Genomic Toolkit with Israel-based Igentify's genetic counseling software, which both firms will comarket.
PerkinElmer will provide biochemical and genetic testing to support BioMarin's testing program aimed at Batten disease and mucopolysaccharidosis disorders.
Revenues have begun to recover in Q3, driven by a ramp in SARS-CoV-2 testing, and the firm now expects full-year 2020 revenues to exceed its prior guidance.
